Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Stem cell patent enforcement eased

January 29, 2007 | A version of this story appeared in Volume 85, Issue 5

The Wisconsin Alumni Research Foundation (WARF) has announced three policy changes to the licensing terms covering the set of patents it holds on primate embryonic stem cells. The policy changes come as the U.S. Patent & Trademark Office is reviewing the validity of the patents (C&EN, Jan. 15, page 31). The first policy change will allow industry-sponsored research to be done at academic or nonprofit institutions without a license from WARF. A company will still need to obtain a license once the work moves into its labs or the work is being developed into a commercial product. Another change in policy will allow researchers to transfer WARF cells to others for free. Previously, such transfers required a license. The final change clarifies WARF's position related to the California Institute for Regenerative Medicine (CIRM), a nonprofit, grant-making organization set up to distribute stem cell research funds created by the state's $3 billion bond initiative. The change clears CIRM to make grants to and collect funds from its grantees without remitting any payment to WARF.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.